As of 2025-07-15, the EV/EBITDA ratio of Rapid Dose Therapeutics Corp (DOSE.CN) is -8.24. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DOSE.CN's latest enterprise value is 32.38 mil CAD. DOSE.CN's TTM EBITDA according to its financial statements is -3.93 mil CAD. Dividing these 2 quantities gives us the above DOSE.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.0x - 5.9x | 5.0x |
| Forward P/E multiples | 5.2x - 7.7x | 6.4x |
| Fair Price | (0.18) - (0.20) | (0.19) |
| Upside | -176.8% - -187.1% | -183.9% |
| Date | EV/EBITDA |
| 2025-07-10 | -7.58 |
| 2025-07-09 | -7.25 |
| 2025-07-08 | -6.92 |
| 2025-07-07 | -6.75 |
| 2025-07-04 | -6.59 |
| 2025-07-03 | -7.25 |
| 2025-07-02 | -7.25 |
| 2025-06-30 | -6.75 |
| 2025-06-27 | -7.58 |
| 2025-06-26 | -7.25 |
| 2025-06-24 | -7.25 |
| 2025-06-23 | -6.92 |
| 2025-06-20 | -7.91 |
| 2025-06-19 | -7.91 |
| 2025-06-18 | -8.24 |
| 2025-06-17 | -7.25 |
| 2025-06-16 | -7.91 |
| 2025-06-13 | -7.58 |
| 2025-06-12 | -7.08 |
| 2025-06-11 | -7.91 |
| 2025-06-10 | -7.58 |
| 2025-06-09 | -7.58 |
| 2025-06-06 | -7.08 |
| 2025-06-05 | -8.07 |
| 2025-06-04 | -7.25 |
| 2025-06-03 | -7.91 |
| 2025-06-02 | -8.07 |
| 2025-05-30 | -7.58 |
| 2025-05-29 | -7.58 |
| 2025-05-28 | -6.92 |
| 2025-05-27 | -7.58 |
| 2025-05-26 | -6.92 |
| 2025-05-23 | -6.92 |
| 2025-05-22 | -7.58 |
| 2025-05-21 | -7.91 |
| 2025-05-20 | -8.40 |
| 2025-05-16 | -7.08 |
| 2025-05-15 | -7.08 |
| 2025-05-14 | -6.92 |
| 2025-05-13 | -7.08 |
| 2025-05-12 | -7.08 |
| 2025-05-09 | -6.92 |
| 2025-05-08 | -6.92 |
| 2025-05-07 | -6.92 |
| 2025-05-06 | -7.41 |
| 2025-05-05 | -7.25 |
| 2025-05-01 | -7.25 |
| 2025-04-30 | -7.25 |
| 2025-04-29 | -7.08 |
| 2025-04-28 | -6.92 |